Published in Glycoconj J on June 01, 1999
Sialic acids in human health and disease. Trends Mol Med (2008) 2.61
Mucins and mucosal protection in the gastrointestinal tract: new prospects for mucins in the pathology of gastrointestinal disease. Gut (2000) 1.99
Metabolism of sialic acid by Bifidobacterium breve UCC2003. Appl Environ Microbiol (2014) 0.97
On the relationship between sialomucin and sulfomucin expression and hydrogenotrophic microbes in the human colonic mucosa. PLoS One (2011) 0.95
Sialic acid metabolism and sialyltransferases: natural functions and applications. Appl Microbiol Biotechnol (2012) 0.91
Increasing the α 2, 6 sialylation of glycoproteins may contribute to metastatic spread and therapeutic resistance in colorectal cancer. Gut Liver (2013) 0.88
High level of sialate-O-acetyltransferase activity in lymphoblasts of childhood acute lymphoblastic leukaemia (ALL): enzyme characterization and correlation with disease status. Glycoconj J (2008) 0.86
The interaction of large bowel microflora with the colonic mucus barrier. Int J Inflam (2010) 0.82
Investigations on aberrant glycosylation of glycosphingolipids in colorectal cancer tissues using liquid chromatography and matrix-assisted laser desorption time-of-flight mass spectrometry (MALDI-TOF-MS). Mol Cell Proteomics (2013) 0.82
O-acetylation of sialic acids is required for the survival of lymphoblasts in childhood acute lymphoblastic leukemia (ALL). Glycoconj J (2007) 0.81
9-O-acetylated sialoglycoproteins are important immunomodulators in Indian visceral leishmaniasis. Clin Vaccine Immunol (2009) 0.81
Identification of 9-O-acetyl-N-acetylneuraminic acid in normal canine pre-ocular tear film secreted mucins and its depletion in Keratoconjunctivitis sicca. Glycoconj J (2005) 0.80
Pathobiological implications of mucin glycans in cancer: Sweet poison and novel targets. Biochim Biophys Acta (2015) 0.78
Lectins from the Red Marine Algal Species Bryothamnion seaforthii and Bryothamnion triquetrum as Tools to Differentiate Human Colon Carcinoma Cells. Adv Pharmacol Sci (2009) 0.77
A Preliminary Study Examining the Binding Capacity of Akkermansia muciniphila and Desulfovibrio spp., to Colonic Mucin in Health and Ulcerative Colitis. PLoS One (2015) 0.77
Eukaryotic protein glycosylation: a primer for histochemists and cell biologists. Histochem Cell Biol (2016) 0.75
Fucosylation is associated with the malignant transformation of intraductal papillary mucinous neoplasms: a lectin microarray-based study. Surg Today (2016) 0.75
Bifidobacterium bifidum Extracellular Sialidase Enhances Adhesion to the Mucosal Surface and Supports Carbohydrate Assimilation. MBio (2017) 0.75
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem (1976) 903.81
Diversity in the sialic acids. Glycobiology (1992) 2.60
Mucin degradation in the human colon: production of sialidase, sialate O-acetylesterase, N-acetylneuraminate lyase, arylesterase, and glycosulfatase activities by strains of fecal bacteria. Infect Immun (1992) 1.78
Racial variation in the O-acetylation phenotype of human colonic mucosa. J Pathol (1994) 1.62
Neoplastic transformation of a human colonic epithelial cell line: in vitro evidence for the adenoma to carcinoma sequence. Cancer Res (1990) 1.57
Colorectal goblet cell sialomucin heterogeneity: its relation to malignant disease. J Clin Pathol (1986) 1.41
Determination of mono-O-acetylated N-acetylneuraminic acids in human and rat sera by fluorometric high-performance liquid chromatography. Anal Biochem (1989) 1.38
Modifications of cell surface sialic acids modulate cell adhesion mediated by sialoadhesin and CD22. Glycoconj J (1994) 1.30
Crypt restricted heterogeneity of goblet cell mucus glycoprotein in histologically normal human colonic mucosa: a potential marker of somatic mutation. Br J Cancer (1990) 1.25
Monoclonal antibodies to human colorectal epithelium: markers for differentiation and tumour characterization. Int J Cancer (1987) 1.23
The release and purification of sialic acids from glycoconjugates: methods to minimize the loss and migration of O-acetyl groups. Anal Biochem (1984) 1.23
Degradation by bacterial enzymes of colonic mucus from normal subjects and patients with inflammatory bowel disease: the role of sialic acid metabolism and the detection of a novel O-acetylsialic acid esterase. Clin Sci (Lond) (1988) 1.23
Natural ligands of the B cell adhesion molecule CD22 beta can be masked by 9-O-acetylation of sialic acids. J Cell Biol (1994) 1.22
Binding of Plasmodium falciparum 175-kilodalton erythrocyte binding antigen and invasion of murine erythrocytes requires N-acetylneuraminic acid but not its O-acetylated form. Mol Biochem Parasitol (1992) 1.20
Migration of O-acetyl groups in N,O-acetylneuraminic acids. Eur J Biochem (1987) 1.15
Sialic acid and epithelial differentiation in colorectal polyps and cancer--a morphological, mucin and lectin histochemical study. Pathology (1992) 1.13
The roles of enteric bacterial sialidase, sialate O-acetyl esterase and glycosulfatase in the degradation of human colonic mucin. Glycoconj J (1993) 1.12
Colonic mucins in ulcerative colitis: evidence for loss of sulfation. Glycoconj J (1996) 1.11
O-glycan biosynthesis in human colorectal adenoma cells during progression to cancer. Eur J Biochem (1994) 1.09
Colorectal mucin histochemistry in health and disease: a critical review. Pathol Int (1994) 1.03
Basis of sialic acid heterogeneity in ulcerative colitis. J Clin Pathol (1988) 1.01
9-O-acetylated sialic acids have widespread but selective expression: analysis using a chimeric dual-function probe derived from influenza C hemagglutinin-esterase. Proc Natl Acad Sci U S A (1994) 0.99
Determination of sialic acids. Methods Enzymol (1994) 0.98
Transitional mucosa and survival in human colorectal cancer. Cancer (1980) 0.95
South Asian and European colitics show characteristic differences in colonic mucus glycoprotein type and turnover. Gut (1995) 0.95
N-acetyl-9-O-acetylneuraminic acid, the receptor determinant for influenza C virus, is a differentiation marker on chicken erythrocytes. Biol Chem Hoppe Seyler (1987) 0.92
CDw60 glycolipid antigens of human leukocytes: structural characterization and cellular distribution. Blood (1993) 0.89
Glycosylation patterns of mucins in colonic disease. Biochem Soc Trans (1995) 0.89
Immobilized Clostridium perfringens neuraminidase. Substrate cleavage and enzyme release during incubation. Hoppe Seylers Z Physiol Chem (1977) 0.89
Distribution of mono-, di, and tri-O-acetylated sialic acids in normal and neoplastic colon. Cancer Res (1988) 0.87
The carbohydrate composition of mucin in colonic cancer. Gastroenterology (1990) 0.87
Loss of sialic acid O-acetylation in human colorectal cancer cells. Biochem Soc Trans (1992) 0.85
Tumor-associated sialylated antigens are constitutively expressed in normal human colonic mucosa. Cancer Res (1995) 0.84
Characterization of a sialic-acid-rich mucus glycoprotein secreted by a premalignant human colorectal adenoma cell line. Int J Cancer (1990) 0.83
Sialic acids: metabolism of O-acetyl groups. Methods Enzymol (1987) 0.83
Antigen expression in normal and neoplastic colonic mucosa: three tissue-specific antigens using monoclonal antibodies to isolated colonic glands. Cancer Res (1986) 0.82
Mucin abnormality of colonic mucosa in ulcerative colitis associated with carcinoma and/or dysplasia. Dis Colon Rectum (1988) 0.80
O-acetyl GD3 ganglioside in human peripheral blood T lymphocytes. Int Immunol (1994) 0.80
Monoclonal antibody TKH2 to the cancer-associated epitope sialosyl Tn shows cross-reactivity with variants of normal colorectal goblet cell mucin. Pathology (1994) 0.80
Binding specificity of influenza C-virus to variably O-acetylated glycoconjugates and its use for histochemical detection of N-acetyl-9-O-acetylneuraminic acid in mammalian tissues. Glycoconj J (1996) 0.80
Low O-acetylation of sialyl-Le(x) contributes to its overexpression in colon carcinoma metastases. Int J Cancer (1997) 0.79
Sialic acid histochemistry and the adenoma-carcinoma sequence in colorectum. J Clin Pathol (1990) 0.79
Histochemical identification of side chain substituted O-acylated sialic acids: the PAT-KOH-Bh-PAS and the PAPT-KOH-Bh-PAS procedures. Histochem J (1984) 0.79
Histochemical alterations of mucin in normal colon, inflammatory bowel disease and colonic adenocarcinoma. Histochem J (1995) 0.78
Characterization of the major and minor mucus glycoproteins from bovine submandibular gland. Glycoconj J (1991) 0.78
Sialic acid in colonic mucin: an evaluation of modified PAS reactions in single and combination histochemical procedures. Histochem J (1989) 0.78
Analysis of cancer-associated colonic mucin by ion-exchange chromatography: evidence for a mucin species of lower molecular charge and weight in cancer. Biochim Biophys Acta (1989) 0.78
A single human colonic adenoma cell line can be converted in vitro to both a colorectal adenocarcinoma and a mucinous carcinoma. Int J Cancer (1992) 0.77
Sialic acids in human gastric aspirates: detection of 9-O-lactyl- and 9-O-acetyl-N-acetylneuraminic acids and a decrease in total sialic acid concentration with age. Clin Sci (Lond) (1993) 0.77
Chemical and histochemical studies of normal and diseased gastrointestinal tract. IV. A comparison of histochemical and chemical methods for the estimation of side chain O-acylated sialic acids. Histochem J (1985) 0.75
Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol (2005) 10.16
Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet (1986) 10.07
p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res (1990) 5.70
European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. Gut (2006) 3.57
Chemistry, metabolism, and biological functions of sialic acids. Adv Carbohydr Chem Biochem (1982) 3.53
The APC gene product in normal and tumor cells. Proc Natl Acad Sci U S A (1993) 3.25
Anatomy of Denonvilliers' fascia and pelvic nerves, impotence, and implications for the colorectal surgeon. Br J Surg (2000) 2.45
Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug: independence from COX-2 protein expression. Clin Cancer Res (1997) 2.33
Epigenetic silencing of the intronic microRNA hsa-miR-342 and its host gene EVL in colorectal cancer. Oncogene (2008) 2.26
Management of early rectal cancer. Br J Surg (2008) 2.13
VEGF 165 b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: balance of pro- and antiangiogenic VEGF-A isoforms has implications for therapy. Br J Cancer (2008) 2.09
Sialoadhesin, myelin-associated glycoprotein and CD22 define a new family of sialic acid-dependent adhesion molecules of the immunoglobulin superfamily. Curr Biol (1994) 2.05
The isolation and characterization of colorectal epithelial cell lines at different stages in malignant transformation from familial polyposis coli patients. Int J Cancer (1984) 2.04
Increased dosage and amplification of the focal adhesion kinase gene in human cancer cells. Oncogene (1999) 2.00
European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis. J Crohns Colitis (2008) 1.99
Mucins and mucosal protection in the gastrointestinal tract: new prospects for mucins in the pathology of gastrointestinal disease. Gut (2000) 1.99
Mucins in the gastrointestinal tract in health and disease. Front Biosci (2001) 1.99
Butyrate acts as a survival factor for colonic epithelial cells: further fuel for the in vivo versus in vitro debate. Gastroenterology (1997) 1.99
Sodium butyrate induces apoptosis in human colonic tumour cell lines in a p53-independent pathway: implications for the possible role of dietary fibre in the prevention of large-bowel cancer. Int J Cancer (1993) 1.94
Structure, function and metabolism of sialic acids. Cell Mol Life Sci (1998) 1.85
Conserved sequences in bacterial and viral sialidases. Glycoconj J (1989) 1.84
Sialic acids in molecular and cellular interactions. Int Rev Cytol (1997) 1.79
The receptor-destroying enzyme of influenza C virus is neuraminate-O-acetylesterase. EMBO J (1985) 1.76
Prognostic significance of DNA aneuploidy and cell proliferation in rectal adenocarcinomas. J Pathol (1987) 1.70
Local excision of rectal tumours by transanal endoscopic microsurgery. Br J Surg (2007) 1.66
An acidic environment leads to p53 dependent induction of apoptosis in human adenoma and carcinoma cell lines: implications for clonal selection during colorectal carcinogenesis. Oncogene (1999) 1.64
Progression of colorectal cancer is associated with multiple tumor suppressor gene defects but inhibition of tumorigenicity is accomplished by correction of any single defect via chromosome transfer. Mol Cell Biol (1992) 1.62
Neoplastic transformation of a human colonic epithelial cell line: in vitro evidence for the adenoma to carcinoma sequence. Cancer Res (1990) 1.57
Characterization of sialic acids. Methods Enzymol (1978) 1.55
N-Glycolylneuraminic acid in human tumours. Biochimie (2001) 1.55
Apoptosis in colorectal tumour cells: induction by the short chain fatty acids butyrate, propionate and acetate and by the bile salt deoxycholate. Int J Cancer (1995) 1.54
Purification and properties of cloned Salmonella typhimurium LT2 sialidase with virus-typical kinetic preference for sialyl alpha 2----3 linkages. J Biochem (1991) 1.50
Effect of neoadjuvant chemotherapy on circumferential margin positivity and its impact on prognosis in patients with resectable oesophageal cancer. Br J Surg (2008) 1.50
Apparent deficiency of mucosal vascular collagen type IV associated with angiodysplasia of the colon. J Clin Pathol (1998) 1.49
The transmembrane form of the CX3CL1 chemokine fractalkine is expressed predominantly by epithelial cells in vivo. Am J Pathol (2001) 1.49
The proportion of tumor-stroma as a strong prognosticator for stage II and III colon cancer patients: validation in the VICTOR trial. Ann Oncol (2012) 1.46
Diversion colitis and involution of the defunctioned anorectum. Gut (1993) 1.46
Apoptosis is induced by the active metabolite of vitamin D3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: possible implications for prevention and therapy. Cancer Res (2000) 1.44
The outcome following sphincter-saving resection and abdominoperineal resection for low rectal cancer. Br J Surg (1985) 1.41
Dukes' staging is poorly understood by doctors managing colorectal cancer. Ann R Coll Surg Engl (2002) 1.41
The sialidase superfamily and its spread by horizontal gene transfer. Mol Microbiol (1993) 1.40
Transmissible gastroenteritis coronavirus, but not the related porcine respiratory coronavirus, has a sialic acid (N-glycolylneuraminic acid) binding activity. J Virol (1996) 1.40
Colorectal cancer and dietary calcium intervention: a word of caution. Eur J Cancer Prev (1992) 1.39
Cloning and sequencing of a Clostridium perfringens sialidase gene. FEBS Lett (1988) 1.39
Who was Sago? Histopathology (1990) 1.38
Colonoscopy or barium enema as initial investigation of colonic disease. Lancet (1987) 1.37
Fat-wrapping in Crohn's disease: pathological basis and relevance to surgical practice. Br J Surg (1992) 1.36
A study of ras gene mutations in colonic adenomas from familial polyposis coli patients. Oncogene (1988) 1.35
BCL-2 expression in human colorectal adenomas and carcinomas. Oncogene (1994) 1.34
CDX1 is an important molecular mediator of Barrett's metaplasia. Proc Natl Acad Sci U S A (2005) 1.34
Preoperative chemoradiotherapy and total mesorectal excision surgery for locally advanced rectal cancer: correlation with rectal cancer regression grade. Dis Colon Rectum (2004) 1.32
Modifications of cell surface sialic acids modulate cell adhesion mediated by sialoadhesin and CD22. Glycoconj J (1994) 1.30
The specificity of viral and bacterial sialidases for alpha(2-3)- and alpha(2-6)-linked sialic acids in glycoproteins. Biochim Biophys Acta (1983) 1.29
Functional groups of sialic acids involved in binding to siglecs (sialoadhesins) deduced from interactions with synthetic analogues. Eur J Biochem (1998) 1.29
A study to determine the reasons for differences in the tumorigenicity of rat cell lines transformed by adenovirus 2 and adenovirus 12. Cold Spring Harb Symp Quant Biol (1980) 1.27
The catalytic activity of the Src family kinases is required to disrupt cadherin-dependent cell-cell contacts. Mol Biol Cell (2000) 1.26
The African enigma: low prevalence of gastric atrophy, high prevalence of chronic inflammation in West African adults and children. Helicobacter (2001) 1.25
A role for epidermal growth factor receptor, c-Src and focal adhesion kinase in an in vitro model for the progression of colon cancer. Oncogene (1997) 1.23
Isolation and characterization of a trisialoganglioside from mouse brain, containing 9-O-acetyl-N-acetylneuraminic acid. J Biol Chem (1980) 1.23
Mobilisation of enterocyte fat stores by oral glucose in humans. Gut (2003) 1.22
Siglecs: a family of sialic-acid binding lectins. Glycobiology (1998) 1.22
[Action specificity of neuraminidase. The action of bacterial neuraminidase on isomeric N,O-diacetylneuraminic acid glycosides in the submaxilllary mucin of horse and cow]. Hoppe Seylers Z Physiol Chem (1968) 1.21
Cancer surveillance in ulcerative colitis. Br J Surg (2005) 1.20
Binding of Plasmodium falciparum 175-kilodalton erythrocyte binding antigen and invasion of murine erythrocytes requires N-acetylneuraminic acid but not its O-acetylated form. Mol Biochem Parasitol (1992) 1.20
[Surgical techniques in hepatic resections: Ultrasonic aspirator versus Jet-Cutter. A prospective randomized clinical trial]. Zentralbl Chir (2001) 1.20
Insulin-like growth factor binding protein 3 (IGFBP-3) potentiates TRAIL-induced apoptosis of human colorectal carcinoma cells through inhibition of NF-kappaB. Cell Death Differ (2006) 1.19
Abnormal retention of intron 9 in CD44 gene transcripts in human gastrointestinal tumors. Cancer Res (1995) 1.18
Effects of Pringle manoeuvre and ischaemic preconditioning on haemodynamic stability in patients undergoing elective hepatectomy: a randomized trial. Br J Anaesth (2004) 1.18
Migration of O-acetyl groups in N,O-acetylneuraminic acids. Eur J Biochem (1987) 1.15
Tumorigenicity and in vitro characteristics of rat liver epithelial cells and their adenovirus-transformed derivatives. Int J Cancer (1980) 1.15
Heparan sulfate undergoes specific structural changes during the progression from human colon adenoma to carcinoma in vitro. J Biol Chem (1998) 1.14
The biosynthesis of N-glycoloylneuraminic acid occurs by hydroxylation of the CMP-glycoside of N-acetylneuraminic acid. Biol Chem Hoppe Seyler (1988) 1.14
Quantification of histologic regression of rectal cancer after irradiation: a proposal for a modified staging system. Dis Colon Rectum (2002) 1.13
The roles of enteric bacterial sialidase, sialate O-acetyl esterase and glycosulfatase in the degradation of human colonic mucin. Glycoconj J (1993) 1.12
The sialidase gene from Clostridium septicum: cloning, sequencing, expression in Escherichia coli and identification of conserved sequences in sialidases and other proteins. Mol Gen Genet (1991) 1.12
Cloning, sequencing and expression of a sialidase gene from Clostridium sordellii G12. J Gen Microbiol (1989) 1.12
Increased p53-dependent apoptosis by the insulin-like growth factor binding protein IGFBP-3 in human colonic adenoma-derived cells. Cancer Res (2000) 1.12
Colonic mucins in ulcerative colitis: evidence for loss of sulfation. Glycoconj J (1996) 1.11
Localization of the putative sialic acid-binding site on the immunoglobulin superfamily cell-surface molecule CD22. J Biol Chem (1996) 1.10
Coordinated modulation of the fibroblast growth factor dual receptor mechanism during transformation from human colon adenoma to carcinoma. Int J Cancer (1999) 1.10
CMP-N-acetylneuraminic acid hydroxylase: the first cytosolic Rieske iron-sulphur protein to be described in Eukarya. FEBS Lett (1996) 1.10
O-glycan biosynthesis in human colorectal adenoma cells during progression to cancer. Eur J Biochem (1994) 1.09
Apoptosis induction and cyclooxygenase-2 regulation in human colorectal adenoma and carcinoma cell lines by the cyclooxygenase-2-selective non-steroidal anti-inflammatory drug NS-398. Int J Cancer (2000) 1.08
An insight into the genetic pathway of adenocarcinoma of the small intestine. Gut (2002) 1.08
The release of N-acetyl- and N-glycolloyl-neuraminic acid from soluble complex carbohydrates and erythrocytes by bacterial, viral and mammalian sialidases. Biochem J (1981) 1.08
Butyrate can act as a stimulator of growth or inducer of apoptosis in human colonic epithelial cell lines depending on the presence of alternative energy sources. Carcinogenesis (1997) 1.07
Sialic acid--a determinant of the life-time of rabbit erythrocytes. Hoppe Seylers Z Physiol Chem (1974) 1.07
Mucin gene expression in Barrett's oesophagus: an in situ hybridisation and immunohistochemical study. Gut (2000) 1.06
Immunodetection of cathepsins B and L present in and secreted from human pre-malignant and malignant colorectal tumour cell lines. Int J Cancer (1989) 1.06
Functional anatomy of human lacrimal duct epithelium. Anat Embryol (Berl) (1998) 1.05
Protein-sugar interactions. Purification by affinity chromatography of limulin, an N-acyl-neuraminidyl-binding protein. FEBS Lett (1975) 1.05
An evaluation of treatment decisions at a colorectal cancer multi-disciplinary team. Colorectal Dis (2008) 1.04
Distribution of mucosal pathology and an assessment of colonic phenotypic change in the pelvic ileal reservoir. Gut (1993) 1.04
Antibodies to ADP-ATP carrier--an autoantigen in myocarditis and dilated cardiomyopathy--impair cardiac function. Circulation (1990) 1.02
TGF-beta expression in the human colon: differential immunostaining along crypt epithelium. Br J Cancer (1993) 1.02